mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |